Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
4 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 1 news category, from Jun 24, 2026 through Jul 19, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
New diagnostic testing methods using saliva and blood analysis are emerging as potential alternatives for identifying endometriosis.
A new blood test, Stockholm3, is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
A new multicomponent blood test is outperforming traditional PSA screenings in detecting clinically significant prostate cancer.